{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:50:04Z","timestamp":1761706204557},"reference-count":20,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T00:00:00Z","timestamp":1122336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p> <jats:bold>Abstract<\/jats:bold> <\/jats:p><jats:p>The need to control chemotherapy\u2010induced emesis has stimulated research into anti\u2010emetics. Emesis is not only unpleasant, but negatively impacts on global quality of life. The development of two new classes of drugs has been responsible for the major advances in anti\u2010emesis. The 5 hydroxytryptamine<jats:sub>3<\/jats:sub> (5HT<jats:sub>3<\/jats:sub>) antagonists in combination with dexamethasone significantly improved the control of acute post chemotherapy emesis, but delayed emesis which can last for several days was still problematic, yet its incidence was underestimated by clinicians. Both the control of acute and delayed emesis was improved when the neurokinin<jats:sub>1<\/jats:sub> (NK<jats:sub>1<\/jats:sub>) receptor antagonists were added to 5HT<jats:sub>3<\/jats:sub> antagonists and steroids. The complete control of delayed emesis was improved by 21% with little toxicity. The triple drug combination has become the standard of care for preventing the emesis associated with cytotoxic drugs of high emetic potential. (Intern Med J 2005; 35: 478\u2212481)<\/jats:p>","DOI":"10.1111\/j.1445-5004.2005.00879.x","type":"journal-article","created":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T18:25:48Z","timestamp":1122402348000},"page":"478-481","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Update on anti\u2010emetics for chemotherapy\u2010induced emesis"],"prefix":"10.1111","volume":"35","author":[{"given":"I. N.","family":"Olver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,26]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050157"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(83)90418-2"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01358879"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.507"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050078"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20230"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010798"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.1050"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg417"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11817"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.0135.x"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11433"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.095"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00066-3"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80128-5"},{"key":"e_1_2_9_17_2","first-page":"14S","article-title":"Effect of aprepitant for the prevention of nausea and vomiting after one cycle of moderately emetogenic chemotherapy: a randomized double\u2010blind trial in 866 patients. 2004 ASCO Annual Meeting Proceedings","volume":"22","author":"Warr DG","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"e_1_2_9_18_2","first-page":"iii218","article-title":"Randomized double\u2010blind trial comparing the effect of an aprepitant regimen versus a standard antiemetic regimen during four cycles of moderately emetogenic chemotherapy","volume":"15","author":"Herrstedt J","year":"2004","journal-title":"Ann Oncol"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-004-0699-x"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.064"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.164"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5004.2005.00879.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5004.2005.00879.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:13:20Z","timestamp":1696875200000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5004.2005.00879.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,26]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1445-5004.2005.00879.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5004.2005.00879.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,26]]},"assertion":[{"value":"2005-07-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}